Daily CSR
Daily CSR

Daily CSR

Daily news about corporate social responsibility, ethics and sustainability
Tags (8) : capital markets

GROW Investment Group Secures ADGM Approval for Middle East Expansion

GROW Investment Group Secures ADGM Approval for Middle East Expansion
04/29/2026 | Companies
GROW Investment Group (GIG), a prominent Chinese asset management firm overseeing nearly $1.5 billion in assets worldwide, announced today that it has secured In-Principle Approval (IPA) from the Financial Services Regulatory Authority (FSRA) of Abu Dhabi Global Market (ADGM). The company...
Abu Dhabi, Abu Dhabi Financial Week, Abu Dhabi Global Market, ADGM, Arvind Ramamurthy, Bank Julius Baer, capital markets, China GCC relations, Chinese asset manager, Chinese capital markets, cross border investment, economic integration, family offices, financial ecosystem, financial hub, financial services, FSRA, GCC, GIG, global asset management, global financial center, global investments, GROW Investment Group, Gulf Cooperation Council, high net worth individuals, institutional investors, international finance, investment opportunities, Lighthouse hedge fund, Middle East expansion, offshore asset management, onshore asset management, regulatory approval, sovereign wealth funds, wealth management, William Ma

Lakewood-Amedex Appoints Joseph Tucker to Board After Nasdaq Listing

Lakewood-Amedex Appoints Joseph Tucker to Board After Nasdaq Listing
04/28/2026 | Companies
Lakewood-Amedex Biotherapeutics Inc, a clinical-stage biotech firm focused on developing a new category of powerful, rapid-acting, broad-spectrum antimicrobials known as the Bisphosphocin® class, has announced the addition of Joseph Tucker, Ph.D., to its Board of Directors. Dr. Tucker, who...
antibiotic resistance, antimicrobial drugs, biotech leadership, biotechnology, Bisphosphocin, board of directors, capital markets, clinical trials, clinical-stage biotech, corporate governance, diabetic foot ulcers, drug development, Enveric Biosciences, healthcare innovation, Joseph Tucker, Lakewood-Amedex Biotherapeutics, Nasdaq listing, neurological disorders, neuropsychiatric disorders, Nu-3, pipeline development, small-molecule therapeutics, strategic growth

Tharimmune Becomes Super Validator on Canton Network, Boosting On-Chain Finance and Digital Asset Growth

Tharimmune Becomes Super Validator on Canton Network, Boosting On-Chain Finance and Digital Asset Growth
01/27/2026 | Companies
Tharimmune, Inc., the first publicly traded company to utilize Canton Coin ("CC") in support of the Canton Network’s mission to digitize traditional financial markets, has announced its approval to operate as a Super Validator on the network. This designation enhances Tharimmune’s role in securing...
atomic settlement, blockchain, Canton Coin, Canton Network, capital markets, CC, community development, digital asset treasury, digital assets, financial infrastructure, financial markets, institutional adoption, network security, on-chain finance, on-chain transactions, programmable privacy, quarterly research, roadmap updates, Super Validator, Tharimmune, tokenomics, webinars

Aldabra 4 Liquidity Opportunity Vehicle Prices $261M IPO on Nasdaq

Aldabra 4 Liquidity Opportunity Vehicle Prices $261M IPO on Nasdaq
01/22/2026 | Companies
Aldabra 4 Liquidity Opportunity Vehicle, Inc. (the “Company”), a special purpose acquisition company established to pursue a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization, or similar transaction with one or more businesses, announced on January 21, 2026,...
$10 per unit, Aldabra 4 Liquidity Opportunity Vehicle, ALOV, ALOVU, ALOVW, blank check company, business combination, Cantor Fitzgerald, capital markets, Chardan, Class A ordinary shares, equity markets, forward-looking statements, Inc., initial public offering, IPO, Ladenburg Thalmann, merger and acquisition, Nasdaq Global Market, prospectus, public listing, redeemable warrants, registration statement, securities offering, SPAC, The Benchmark Company, U.S. SEC

Ribo Life Science Lists on HKEX, Raising HKD 1.8 Billion in siRNA IPO

Ribo Life Science Lists on HKEX, Raising HKD 1.8 Billion in siRNA IPO
01/09/2026 | Companies
Ribo Life Science Co., Ltd, a pioneer in the development of small interfering RNA (siRNA) therapies, has successfully debuted on the Main Board of the Hong Kong Stock Exchange. This achievement represents an important step forward for the capitalization of China’s biopharmaceutical sector in the...
biopharmaceutical industry, biotechnology innovation, capital markets, Chinese biotech, clinical trials, cornerstone investors, drug development, global offering, healthcare innovation, HKEX IPO, Hong Kong Stock Exchange, investor confidence, liver-targeted delivery, research and development, Ribo Life Science, RiboGalSTAR, RNA interference, siRNA therapeutics

Nasdaq announces Science Based Targets initiative to achieve emissions reduction targets

Nasdaq announces Science Based Targets initiative to achieve emissions reduction targets
11/28/2022 | Companies
Nasdaq announced today that The Science Based Targets initiative has approved its near- and long-term science-based emissions reduction targets. Nasdaq has committed to reducing absolute Scope 1 and Scope 2 GHG emissions by 100% and absolute Scope 3 GHG emissions by 50% by 2030. SBTi has also...
capital markets, carbon footprint, climate strategy, economic progress, emissions reduction targets, environment, ESG, GHG emissions, governance, long term, long term impacts, measurable, Nasdaq, near term, net zero emissions, SBTi, Science Based Targets, Scope 1, Scope 2, Scope 3, social, sustainable

Northern Trust Asset Management – purpose driven stewardship with sustainable investing

Northern Trust Asset Management – purpose driven stewardship with sustainable investing
08/16/2022 | Companies
The following is from Northern Trust's 2021 Stewardship Report. Northern Trust Asset Management is a global investment manager which has more than $1.3 trillion assets under its management. Northern Trust Asset Management helps investors navigate changing market environments by combining robust...
assets under management, AUM, capital market assumptions, capital markets, climate transition risks, enhancing, environmental, ESG, ESG analysis, ESG criteria, financial performance, global investment manager, governance, healthy, index providers, investment manager, investment returns, investors, long term, Northern Trust Asset Management, policy makers, portfolio construction, protecting, regulators, research, risk adjusted, risk management, social, stakeholder centric, vendors

G&A Institute Provides ‘Exciting’ Pace Of ‘Corporate Sustainability’ & ‘Sustainable Investment’ Coverage

G&A Institute Provides ‘Exciting’ Pace Of ‘Corporate Sustainability’ & ‘Sustainable Investment’ Coverage
02/22/2018 | Economics
The year of 2018, creates “exciting” pace of work done in the fields of sustainability in the corporate sector along with sustainable investment, whereby creating a promise filled year ahead. Dailycsr.com – 22 February 2018 – The “Governance & Accountability Institute, Inc.” informs that within...
capital markets, corporate sustainability, CSR, G&A Institute, Governance & Accountability Institute, ISS, QualityScores, Sustainable Companies, Sustainable Investing, To the Point, web-based platform


Want to write a piece for Daily CSR? Please contact us by email at editor[@]dailycsr.com